Docusign (NASDAQ:DOCU) Price Target Raised to $90.00

Docusign (NASDAQ:DOCU) had its price target lifted by Morgan Stanley from $86.00 to $90.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have an equal weight rating on the stock.

Several other research analysts have also weighed in on DOCU. JMP Securities reissued a “market outperform” rating and set a $124.00 price objective on shares of Docusign in a research note on Friday, September 5th. Wedbush reduced their price target on shares of Docusign from $100.00 to $85.00 and set a “neutral” rating on the stock in a research report on Thursday, June 12th. Wells Fargo & Company upped their price objective on shares of Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Friday, September 5th. Citigroup lifted their target price on Docusign from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, September 4th. Finally, Needham & Company LLC restated a “hold” rating on shares of Docusign in a report on Friday, September 5th. Four analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $94.14.

Docusign Stock Down 1.2%

NASDAQ:DOCU opened at $78.82 on Monday. Docusign has a 12-month low of $54.31 and a 12-month high of $107.86. The stock’s fifty day simple moving average is $75.69 and its 200-day simple moving average is $79.29. The firm has a market capitalization of $15.85 billion, a P/E ratio of 59.26, a P/E/G ratio of 4.18 and a beta of 1.02.

Docusign (NASDAQ:DOCU) last released its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities research analysts expect that Docusign will post 1.17 earnings per share for the current year.

Docusign announced that its board has initiated a stock buyback plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Insider Transactions at Docusign

In related news, insider Robert Chatwani sold 22,875 shares of Docusign stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total value of $1,710,821.25. Following the sale, the insider owned 72,126 shares of the company’s stock, valued at approximately $5,394,303.54. This trade represents a 24.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $74.37, for a total value of $39,713.58. Following the transaction, the director directly owned 8,805 shares of the company’s stock, valued at approximately $654,827.85. This trade represents a 5.72% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 78,552 shares of company stock valued at $5,983,631. 1.01% of the stock is currently owned by company insiders.

Institutional Trading of Docusign

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. New Age Alpha Advisors LLC boosted its holdings in Docusign by 738.2% during the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company’s stock worth $3,353,000 after purchasing an additional 36,273 shares during the last quarter. Pinpoint Asset Management Ltd lifted its position in Docusign by 54.3% during the 1st quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company’s stock worth $4,639,000 after buying an additional 20,043 shares in the last quarter. Concurrent Investment Advisors LLC acquired a new position in shares of Docusign during the 1st quarter worth about $618,000. Gilman Hill Asset Management LLC boosted its stake in shares of Docusign by 4.9% during the 1st quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company’s stock worth $6,864,000 after buying an additional 3,904 shares during the last quarter. Finally, Blair William & Co. IL grew its holdings in shares of Docusign by 1.7% in the 1st quarter. Blair William & Co. IL now owns 387,542 shares of the company’s stock valued at $31,546,000 after acquiring an additional 6,460 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.